Yohei Norimatsu

Limited Efficacy of α-Conopeptides, Vc1.1 and RgIA, To Inhibit Sensory Neuron CaV Current,,

Andrew B. Wright, J. McIntosh, K. Elmslie, 2015, eNeuro.

Cystic fibrosis transmembrane conductance regulator: a molecular model defines the architecture of the anion conduction path and locates a "bottleneck" in the pore.

Anthony Ivetac, M. Sansom, A. Ivetac, 2012, Biochemistry.

channels in identified muscle afferent neurons Tetrodotoxin-resistant voltage-dependent sodium

Andrew B. Wright, J. McIntosh, Ben Katz, 2015 .

Aqueous cigarette smoke extract induces a voltage-dependent inhibition of CFTR expressed in Xenopus oocytes.

K. MacDonald, Y. Norimatsu, D. C. Dawson, 2014, American journal of physiology. Lung cellular and molecular physiology.

Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP(4)).

K. MacDonald, Y. Norimatsu, A. R. Moran, 2012, Biochemical and biophysical research communications.

Exploring the determinants of trace amine-associated receptor 1's functional selectivity for the stereoisomers of amphetamine and methamphetamine.

D. Grandy, J. Bunzow, K. Suchland, 2014, Journal of medicinal chemistry.

External Zn2+ binding to cysteine‐substituted cystic fibrosis transmembrane conductance regulator constructs regulates channel gating and curcumin potentiation

Guangyu Wang, Y. Norimatsu, Rheeann Linsley, 2016, The FEBS journal.

CFTR: A molecular model defines the architecture of the anion conduction path and locates a “bottleneck” in the pore

M. Sansom, A. Ivetac, Y. Norimatsu, 2012 .

Cystic Fibrosis Transmembrane Conductance Regulator: Using Differential Reactivity toward Channel-Permeant and Channel-Impermeant Thiol-Reactive Probes To Test a Molecular Model for the Pore†

Mark Sansom, Xuehong Liu, Anthony Ivetac, 2009, Biochemistry.

Locating a Plausible Binding Site for an Open-Channel Blocker, GlyH-101, in the Pore of the Cystic Fibrosis Transmembrane Conductance Regulator

L. Frye, M. Sansom, A. Ivetac, 2012, Molecular Pharmacology.